PortfoliosLab logoPortfoliosLab logo
CURE vs. CNRG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CURE vs. CNRG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and SPDR S&P Kensho Clean Power ETF (CNRG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -10.45% return, which is significantly lower than CNRG's 23.15% return.


CURE

1D
3.78%
1M
4.14%
YTD
-10.45%
6M
-10.93%
1Y
35.07%
3Y*
1.46%
5Y*
0.46%
10Y*
14.03%

CNRG

1D
-4.63%
1M
-5.18%
YTD
23.15%
6M
19.33%
1Y
95.92%
3Y*
12.18%
5Y*
2.77%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. CNRG - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
CURE
Direxion Daily Healthcare Bull 3x Shares
-10.45%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%-16.35%
CNRG
SPDR S&P Kensho Clean Power ETF
23.15%50.23%-14.48%-11.55%-7.98%-15.68%138.35%63.26%-2.05%

Correlation

The correlation between CURE and CNRG is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (All Time)
Calculated using the full available price history since Oct 23, 2018

0.36

Over the past year, the correlation between CURE and CNRG has dropped to 0.10 - well below their long-term average of 0.36, suggesting their price drivers have been diverging.

CURE vs. CNRG - Sectors Allocation Comparison


Sectors
CURE
CNRG

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

1.6%

Consumer Defensive

-

-

Energy

-

23.5%

Financial Services

-

-

Industrials

-

37.1%

Real Estate

-

-

Technology

-

10.6%

Utilities

-

27.1%

Healthcare

CURE
100.0%
CNRG

-

Basic Materials

CURE

-

CNRG

-

Communication Services

CURE

-

CNRG

-

Consumer Cyclical

CURE

-

CNRG
1.6%

Consumer Defensive

CURE

-

CNRG

-

Energy

CURE

-

CNRG
23.5%

Financial Services

CURE

-

CNRG

-

Industrials

CURE

-

CNRG
37.1%

Real Estate

CURE

-

CNRG

-

Technology

CURE

-

CNRG
10.6%

Utilities

CURE

-

CNRG
27.1%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CURE vs. CNRG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE
CURE Risk / Return Rank: 2424
Overall Rank
CURE Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2727
Sortino Ratio Rank
CURE Omega Ratio Rank: 2424
Omega Ratio Rank
CURE Calmar Ratio Rank: 2424
Calmar Ratio Rank
CURE Martin Ratio Rank: 2222
Martin Ratio Rank

CNRG
CNRG Risk / Return Rank: 7676
Overall Rank
CNRG Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
CNRG Sortino Ratio Rank: 6969
Sortino Ratio Rank
CNRG Omega Ratio Rank: 6767
Omega Ratio Rank
CNRG Calmar Ratio Rank: 9090
Calmar Ratio Rank
CNRG Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. CNRG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and SPDR S&P Kensho Clean Power ETF (CNRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CURECNRGDifference
Sharpe ratioReturn per unit of total volatility

-1.74

Sortino ratioReturn per unit of downside risk

-1.52

Omega ratioGain probability vs. loss probability

1.16

1.38

-0.22

Calmar ratioReturn relative to maximum drawdown

1.13

5.36

-4.22

Martin ratioReturn relative to average drawdown

2.51

13.03

-10.51

CURE vs. CNRG - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.79, which is lower than the CNRG Sharpe Ratio of 2.53. The chart below compares the historical Sharpe Ratios of CURE and CNRG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CURE vs. CNRG - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, roughly equal to the maximum CNRG drawdown of -68.49%. Use the drawdown chart below to compare losses from any high point for CURE and CNRG.


Loading charts...

Drawdown Indicators


CURECNRGDifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-68.49%

-0.70%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-18.01%

-13.09%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-48.77%

-3.16%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-59.17%

+6.94%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

Current Drawdown

Current decline from peak

-28.92%

-19.92%

-9.00%

Average Drawdown

Average peak-to-trough decline

-18.18%

-31.72%

+13.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.98%

7.39%

+6.59%

Volatility

CURE vs. CNRG - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) and SPDR S&P Kensho Clean Power ETF (CNRG) have volatilities of 15.41% and 15.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CURECNRGDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.41%

15.67%

-0.26%

Volatility (6M)

Calculated over the trailing 6-month period

31.09%

27.25%

+3.84%

Volatility (1Y)

Calculated over the trailing 1-year period

44.49%

38.05%

+6.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.92%

34.47%

+9.45%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.58%

35.98%

+13.60%

CURE vs. CNRG - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than CNRG's 0.45% expense ratio.


Dividends

CURE vs. CNRG - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.19%, more than CNRG's 1.11% yield.


PositionTTM202520242023202220212020201920182017
CNRG
SPDR S&P Kensho Clean Power ETF
1.11%1.46%1.34%1.17%1.23%1.34%0.69%1.16%0.35%0.00%
CURE
Direxion Daily Healthcare Bull 3x Shares
1.19%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%

Frequently Asked Questions


CURE and CNRG have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CNRG has higher volatility (15.67%) compared to CURE (15.41%). In terms of maximum drawdown, CURE dropped -69.19% vs CNRG's -68.49%.

On 5-year performance, CNRG leads with 2.77% vs 0.46% for CURE. On fees, CNRG is cheaper at 0.45% per year. On volatility, CURE has been the lower-risk option at 15.41%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, CNRG has performed better with a 2.77% return vs 0.46%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CNRG is cheaper with a 0.45% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.19%, compared with 1.11% for CNRG.

CURE is categorized as Leveraged Equities, while CNRG is Alternative Energy Equities. CURE tracks Health Care Select Sector Index (300%), while CNRG tracks S&P Kensho Clean Power Index. They also come from different issuers: Direxion and State Street. Their fees differ too: 1.08% for CURE and 0.45% for CNRG.

CNRG currently has the higher Sharpe Ratio (2.53 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and CNRG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer